RIGI and malignant colon neoplasm: However, cGAS,605 STING,605 RIG-I,606,607 MAVS608 and IFN-α/β receptor 1-deficient mice609 develop a higher tumor burden in an azoxymethane/dextran sulfate sodium colon cancer model.